Skip to main content
OpenTrials
Completed

NCT Number: NCT05250427

Awareness, Care & Treatment In Obesity Management - An Observation in Asia Pacific

ACTION APAC is a cross-sectional, observational, descriptive, and exploratory survey-based study without collection of laboratory data. The study is not related to any specific treatment options or pharmaceutical product. Collection of data will be performed via quantitative online survey by a third-party vendor through existing databases/panels in APAC region.

The goal of this study is to provide insights to drive awareness around the needs of People Living with Obesity (PLwO) and Health Care Professionals (HCPs) involved in obesity treatment and management.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Obesity Body Weight Nutrition Disorders Nutritional and Metabolic Diseases Overnutrition Overweight Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Novo Nordisk Investigational Site, Dhaka, Bangladesh

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

People Living with Obesity

  • Informed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
  • Male or female, aged above or equal to 18 years at the time of signing informed consent
  • Lives in one of the target countries
  • Current BMI of at least 25 kg/m^2 for all countries (except Singapore which has current BMI 27 kg/m^2) based on self-reported height and weight

Health Care Professionals

  • Informed consent before any study related activities (study-related activities are any procedure related to recording/collection of data according to protocol)
  • Male or female, aged greater than or equal to 18 years at the time of signing informed consent.
  • Physician
  • Primary Care Providers (PCPs) whose specialty is Family practice, General practice, Internal Medicine
  • Non-PCP Specialties whose specialty is Endocrinologist, Cardiologist, Gastroenterologist, Obstetrics/Gynaecologist, Bariatrics/Obesity Medicine, Nutrition Specialist (physician) Orthopaedist, Aesthetics Medicine
  • Specialty is not surgeon (including bariatric or plastic surgeon)
  • Practices in the target countries
  • In clinical practice for at least 2 years
  • Spends at least 50% time in direct patient care
  • Has seen at least 100 patients in past month
  • Has seen at least 10 patients in past month who have obesity defined as: a patient with a BMI greater than or equal to 25 kg/m^2 for all countries (except Singapore which has current greater than or equal to BMI 27 kg/m^2) with or without comorbidities.

Exclusion criteria

People Living with obesity

  • Previous participation in this study. Participation is defined as having given online consent in this study
  • Currently pregnant
  • Participates in intense fitness or body building programs
  • Has had significant, unintentional weight loss (due to major injury, illness, etc) in the past 6 months
  • Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation

Health Care Providers

  • Previous participation in this study. Participation is defined as having given informed consent in this study.
  • Unwillingness, inability, or language barriers precluding adequate understanding or cooperation

Treatment and study plan

No treatment given

Other

No treatment given

Primary outcomes

  1. Weight loss motivators for improving health of PLwO

    Time frame: At the time of survey response (Day 1)

    Multi-select from defined list

  2. Weight loss barriers for improving health of PLwO

    Time frame: At the time of survey response (Day 1)

    Multi-select from defined list

  3. Weight loss management for improving health of PLwO

    Time frame: At the time of survey response (Day 1)

    Multi-select from defined list

  4. Weight loss responsibility for improving health of PLwO

    Time frame: At the time of survey response (Day 1)

    Multi-select from defined list

  5. Proportion of PLwO who made serious weight loss effort

    Time frame: At the time of survey response (Day 1)

    Number of weight loss efforts; percentage of patients

  6. Response to weight loss discussions

    Time frame: At the time of survey response (Day 1)

    Single select from defined list

  7. Attitudes towards obesity and weight management and Interactions of PLwOs with HCPs

    Time frame: At the time of survey response (Day 1)

    5-point Likert scales

Sponsors and collaborators

Lead sponsor

Novo Nordisk A/S

Industry

Registry information

Acronym: ACTION-APAC

Important dates

Study start
2022
Primary completion
2022
Study completion
2022
First posted
Feb 22, 2022
Registry last updated
Jun 14, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.